KELUN PHARMA(002422) 证券之星·2025-03-27 11:03Core Viewpoint - The announcement details the completion of a share buyback plan by a major shareholder, Yaan State-owned Assets Management Co., Ltd., which has increased its stake in Sichuan Kelun Pharmaceutical Co., Ltd. through a combination of loans and self-funding [1][2][3]. Group 1: Shareholder Information - Yaan State-owned Assets Management Co., Ltd. holds 96,983,174 shares, representing 6.07% of the total share capital as of March 27, 2025 [2][3]. - The shareholder's plan involved a minimum investment of 50 million RMB and a maximum of 99 million RMB, with a target share price not exceeding 37.60 RMB per share [1][2]. Group 2: Implementation of the Buyback Plan - From March 1, 2025, to the date of the announcement, Yaan State-owned Assets Management Co., Ltd. has cumulatively acquired 3,182,100 shares, accounting for 0.20% of the total share capital [2][3]. - The total amount spent on the buyback was approximately 98.98 million RMB, which is within the planned investment range [2][3]. Group 3: Regulatory Compliance - The buyback was conducted in compliance with relevant regulations from the China Securities Regulatory Commission and the Shenzhen Stock Exchange [3][4]. - The company confirmed that the buyback will not affect the control of the company or its major shareholders [4].